News and Trends 24 Aug 2016
While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’
Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen to unprecedented levels in Europe. Gilead’s HIV-1 ‘vaccine’, Truvada, has just been approved for marketing in Europe to stop its spread. The year 2014 brought the highest number of new HIV diagnoses ever recorded in Europe, 94% of which were […]